Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/11 → 31/12/11 |
Funding
- Leukaemia Foundation: A$99,736.00
Targeting novel cell survival programs in AML regulated by Phosphoinositide 3-kinase.
- Guthridge, Mark Andrew (Primary Chief Investigator (PCI))
- Layton, Meredith (Chief Investigator (CI))
- Ekert, Paul (Partner Investigator (PI))
- Lopez, Angel F. (Partner Investigator (PI))
- Shepherd, Peter (Partner Investigator (PI))
Project: Research